Protagenic Therapeutics I...

NASDAQ: PTIX · Real-Time Price · USD
2.92
-0.15 (-4.89%)
At close: Aug 15, 2025, 3:59 PM
2.88
-1.41%
After-hours: Aug 15, 2025, 07:55 PM EDT

Protagenic Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
37.72K 25.14K n/a 1.42K 1.51K 1.51K 1.51K 91.00 n/a n/a n/a n/a n/a n/a 37.00 37.00 37.00
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-5.41M -5.7M -5.27M -6.05M -5.53M -4.53M -3.97M -3.46M -2.96M -3.56M -3.76M -3.6M -4.28M -4.14M -3.82M -4.14M -3.32M
Interest Income
37.7K 43.47K 88.1K 146.03K 221.45K 264.48K 303.25K 276.52K 224.72K 185.79K 126K 83.84K 51.17K 33.21K 576.00 257.00 123.00
Pretax Income
-5.24M -5.53M -5.65M -6.4M -6.01M -5M -3.93M -3.45M -2.91M -3.56M -3.84M -3.8M -4.68M -4.52M -4.16M -4.32M -3.34M
Net Income
-5.24M -5.53M -5.65M -6.4M -6.01M -5M -3.93M -3.43M -2.89M -3.52M -3.8M -3.78M -4.67M -4.52M -4.16M -4.32M -3.34M
Selling & General & Admin
2.05M 1.76M 1.22M 1.24M 1.09M 1.21M 1.4M 1.52M 1.69M 1.97M 2.28M 2.37M 3.06M 3M 2.78M 2.83M 2.1M
Research & Development
3.26M 3.85M 4.05M 4.81M 4.43M 3.32M 2.57M 1.94M 1.27M 1.59M 1.48M 1.23M 1.21M 1.14M 1.03M 1.31M 1.23M
Other Expenses
0.00 0.00 n/a n/a -0.00 -0.00 -0.00 -0.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
5.41M 5.7M 5.27M 6.05M 5.53M 4.53M 3.97M 3.46M 2.96M 3.56M 3.76M 3.6M 4.28M 4.14M 3.82M 4.14M 3.32M
Interest Expense
n/a n/a 12.85K 44.81K 76.42K 107.68K 126.79K 126.79K 134.88K 137.46K 164.82K 247.33K 446.82K 496.91K 531.01K 475.38K 291.13K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
5.41M 5.7M 5.27M 6.05M 5.53M 4.53M 3.97M 3.46M 2.96M 3.56M 3.76M 3.6M 4.28M 4.14M 3.82M 4.14M 3.32M
Income Tax Expense
n/a n/a n/a n/a n/a n/a 6.04K -24.68K -24.68K -37.69K -43.72K -13.35K -13.57K -563 -563 -227 n/a
Shares Outstanding (Basic)
523.18K 6.5M 4.47M 4.44M 4.43M 4.38M 4.33M 4.33M 4.22M 4.32M 4.32M 4.32M 4.31M 4.13M 4.13M 3.62M 2.63M
Shares Outstanding (Diluted)
523.18K 6.5M 4.47M 4.44M 4.43M 4.38M 4.33M 4.33M 4.32M 4.32M 4.32M 4.32M 4.31M 4.13M 4.13M 3.62M 2.63M
EPS (Basic)
-3.58 -1.22 -1.27 -1.45 -1.37 -1.15 -0.91 -0.8 -0.67 -0.82 -0.9 -0.89 -1.18 -1.3 -1.28 -1.49 -1.27
EPS (Diluted)
-3.58 -6.27 -6.32 -6.5 -6.42 -1.15 -0.91 -0.8 -0.67 -0.82 -0.9 -0.89 -1.18 -1.3 -1.28 -1.48 -1.26
EBITDA
-5.2M -5.49M -5.58M -6.32M -5.9M -4.86M -3.8M -3.33M -2.78M -3.42M -3.68M -3.55M -4.23M -4.03M -3.63M -3.85M -3.05M
EBIT
-5.25M -5.54M -5.63M -6.35M -5.92M -4.87M -3.8M -3.33M -2.78M -3.42M -3.68M -3.55M -4.23M -4.03M -3.63M -3.85M -3.05M
Depreciation & Amortization
50.29K 50.29K 64.33K 53.18K 40.7K 28.22K 1.63K 924.27K 1.56M 2.9M 2.9M 1.98M 1.34M 288.00 253.00 265.00 274.00